SYNTHESIS, MOLECULAR DOCKING AND FLUORESCENT PROPERTIES OF NOVEL (E)-3-(9-ETHYL-9H-CARBAZOL-3YL)-1-PHENYLPROP-2-EN-1-ONES

Journal Title: International Journal of Pharmacy and Pharmaceutical Sciences - Year 2014, Vol 6, Issue 10

Abstract

Objective: Synthesis of novel (E)-3-(9-ethyl-9H-carbazol-3yl)-1-phenylprop-2-en-1-ones 3a-i to evaluate for their fluorescence property and anticancer activity on Murine double minutes-2(MDM2) receptor bind p53 and Pheripheral benzodiazepine receptor (PBR) proteins.Methods: A Claisen-Schmidt condensation of 9-ethyl-9H-carbazole-3-carbaldehyde 1 with substituted acetophenones 2a-i was carried out to obtain novel class of a series of (E)-3-(9-ethyl-9H-carbazol-3yl)-1-phenylprop-2-en-1-ones 3a-i. The fluorescent behavior in ethanol and acetone as solvents, in silico docking study against MDM2 receptor bind p53 and PBR proteins was investigated.Results: The fluorescent spectrum of (E)-3-(9-ethyl-9H-carbazol-3yl)-1-phenylprop-2-en-1-ones 3a-i shows a large red shift in acetone and ethanol. The compounds 3a-i exhibits large Stoke’s shifts value ranging from 135.5 to 160.0 nm in ethanol when compared to standard rhodamine B which was 32 nm. Similarly in acetone the compounds 3a-i exhibits large Stoke’s shifts value ranging from 114.5 to 141.0 nm when compared to standard rhodamine B which was 40 nm. The docking study reveals that the (E)-3-(9-ethyl-9H-carbazol-3yl)-1-phenylprop-2-en-1-ones 3a-i were shown excellent interaction with PBR receptor protein with binding energy of -2.643050e+02 to -3.104552e+02 kcal/mol. However, the same target compounds exhibited poor interaction with MDM2-bind p53 receptor cancer protein.Conclusion: The study could further widen the scope for the development of similar new structurally distinct (E)-3-(9-ethyl-9H-carbazol-3yl)-1-phenylprop-2-en-1-ones to identify potential anticancer agents. Also since the fluorescent spectrum of (E)-3-(9-ethyl-9H-carbazol-3yl)-1-phenylprop-2-en-1-ones 3a-i exhibits a large red shift with an increase in the polarity of the solvents, these can also serve as good candidates for biological probes in medicinal field. 

Authors and Affiliations

Jagadeesh N Masagalli, Kittappa M Mahadevan, Preenon Bagchi

Keywords

Related Articles

PRESCRIPTION PATTERN AND COST OF ILLNESS (COI) OF INFLAMMATORY BOWEL DISEASE (IBD) IN A TERTIARY CARE HOSPITAL

Objective: Treatment of Inflammatory Bowel disease (IBD) centers on agents used to relieve inflammatory process. None of the drugs used for IBD are curative; at best they serve to control the disease process. The potenti...

DESIGN, SYNTHESIS AND ANTIFUNGAL EVALUATION OF NOVEL SUBSTITUTED 1, 3, 4-OXADIAZOLES, AND 1, 3, 4-THIADIAZOLES

Objective: The purpose of this research is to evaluate the antifungal activity of synthesized conjugates of thiophene with 1, 3, 4-oxadiazoles and 1, 3, 4-thiadiazoles using in vitro methods.Methods: The series of (IVa-e...

NEW FLUORESCENCE QUENCHING BASED METHOD FOR THE DETERMINATION OF TRANDOLAPRIL IN BULK AND CAPSULES

Objective: The objective of the method was to develop a new, simple, rapid and accurate spectrofluorimetric method for the determination of trandolapril in bulk and capsules.Methods: Trandolapril reacts with fluorescein...

CETYL ALCOHOL AND OLEIC ACID SOPHOROLIPIDS EXHIBIT ANTICANCER ACTIVITY

Objective: Sophorolipids (SLs) are glycolipid biosurfactants that have been shown to have anticancer activity. We investigated the anti-cancer activity of cetyl alcohol sophorolipids (CAS) and oleic acid sophorolipids (O...

EFFECT OF METABOLIC SURGERY ON TYPE 2 DIABETES REMISSION: A MATCHED GROUP ANALYSIS

Objectives: In this study it is proposed to analyse the effect of bariatric metabolic surgery on diabetes remission in obese type 2 diabetic patients compared to conventionally treated similar patients.Methods: A retrosp...

Download PDF file
  • EP ID EP579458
  • DOI -
  • Views 73
  • Downloads 0

How To Cite

Jagadeesh N Masagalli, Kittappa M Mahadevan, Preenon Bagchi (2014). SYNTHESIS, MOLECULAR DOCKING AND FLUORESCENT PROPERTIES OF NOVEL (E)-3-(9-ETHYL-9H-CARBAZOL-3YL)-1-PHENYLPROP-2-EN-1-ONES. International Journal of Pharmacy and Pharmaceutical Sciences, 6(10), 317-325. https://europub.co.uk/articles/-A-579458